Milnacipran (IXEL) in the treatment of anxiodepressive and sexual disorders in patients with noninflammatory syndrome of chronic pelvic pain

Terapevticheskii Arkhiv

Volumn 79, Issue 5, 2007, Pages 81-84

  Selitsky, G V ^a   Kaprin, A D ^a   Izvozchikov, S B ^a   Bolotov, A V ^a   Troshina, A V ^a  

^a NONE

Author keywords

Anxiodepressive disorders; Chronic pelvic pain; Milnacipran; Sexual disorders; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; CYCLOPROPANE DERIVATIVE; MILNACIPRAN;

ADULT; ANXIETY; ARTICLE; DEPRESSION; HUMAN; MALE; PELVIS PAIN SYNDROME; PSYCHOLOGICAL ASPECT; PSYCHOSEXUAL DISORDER; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; ANXIETY; CYCLOPROPANES; DEPRESSION; HUMANS; MALE; PELVIC PAIN; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 34547456937     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Russian source
2. Russian source
3. Russian source
4. Russian source
5. Bair M. J., Robinson R. L., Katon W., Kroenre K. Depression and pain comorbidity: a literature review. Arch. Intern. Med. 2003; 163 (20): 2433-2445.
6. Blumer D., Heibronn M. Chronic pain as a variant of depressive disease. The pain-prone disorder. J. Nerv. Ment. Dis. 1982; 170: 381-406.
7. Lindsay P. G., Wycoff M. The depression-pain syndrome and the response to antidepressants. Psychosomatics 1981; 22: 571-577.
8. Russian source
9. Ressler K. J., Nemeroff C. B. Role of serotoninergic and no-radrenergic systems in the pathophysiology of depression and anxiety disorders. Depress. Anxiety 2000; 12: 2-19.
10. Lautenbacher S., Krieg J.-C Pain perception in psychiatric disorders: a review of the literature. J. Psychiatr. Res. 1994; 49: 109-122.
11. Russian source
12. Russian source
13. Nickel J. C., Nuberg L. M., Hennenfent M. Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatis Collaborative Network. Urology 1999; 54: 229-233.
14. Shoskes D. A. Use of antibiotics in chronic prostatitis syndromes. Can. J. Urol. 2001; 8 (3, suppl. 1): 24-28.
15. Russian source
16. Zermann D.-H, Ishigooka M., Doggweiler R. et al. Chronic prostatitis: a myofascial pain syndrome? Infect. Urol. 1999; 12 (3): 84-92.
17. Guidelines on chronic pelvic pain / Fall M., Baranowski A. P., Fowler C. J. et al. 2003. 4-10.
18. Barbalias G. Á., Meares E. M. Jr., Sant G. R. Prostatodynia: clinical and urodynamic characteristics. J. Urol. (Baltimore) 1983; 130: 514-517.
19. Hellstorm W. J., Schmidt R. A., Lue T. F., Tanagho E. A. Neuromuscular dysfunction in nonbacterial prostatitis. Urology 1987; 30: 183-188.
20. Egan K. J., Krieger J. L. Chronic abacterial prostatitis -a urological chronic pain syndrome? Pain 1997; 69 (3): 213-288.
21. Russian source
22. Russian source
23. Berghuis J. P., Heiman J. R., Rothman I., Berger R. E. Psychological and physical factors involved in chronic idiopathic prostatitis. J. Psychosom. Res. 1996; 41: 313-325.
24. Keltikangas-Jarvinen L., Mueller K., Lehtonen T. Illness behavior and personality changes in patients with chronic prostatitis during two-year followup period. Eur. Urol. 1989; 16: 181-184.
25. Russian source
26. Russian source
27. Russian source
28. McNaughton-Collins M., O'Learly M. P., Litwin M. S. Quality of life is impaired in men with chronic prostatitis results from the NIN Cohort study (abstract). J. Urol. (Baltimore) 2000; 163 (suppl.): 23.
29. Russian source
30. Masters W. N., Johnson V. Human sexual response. Boston: Little, Brown; 1970.
31. Russian source
32. Russian source
33. Spielberger C. D., Gorsuch R. L., Lushene R. E. Manual for the state-trait anxiety inventory. Palo Alto, USA: Consulting Psychologist Press; 1970.
34. Russian source
35. Beck A. T., Ward C. H., Mendelson M. et al. An inventory for measuring depression. Arch. Gen. Psychiatry 1961; 4 (4): 561-571.
36. Rosen R. S., Cappeleri J. C., Smith M. D. et al. Contracting and evaluating the "Sexual Health Inventory for Men: IIEF-5" as diagnostic tool for erectile disfunction (ED). J. Comp. Neurol. 1998; 10 (3): 35.
37. Romero L, Ben N., Casanovas J., Artigas F. Two action are better than one: Avoiding self-inhibition of serotonergic neurons enchances the effect of serotonin uptake inhibitors. Int. Clin. Psychopharm. 1996; 11 (suppl. 4): 1-8.
38. Russian source
39. Tanikawa H. Efficacy of milnacipran in patients with chronic orthopaedic pain including degenerative spondylosis and osteoarthritis. Int. J. Psychiatry Clin. Pract. 2002; 6: 255.
40. Rao S. G., King T. E., Porreca F. Analgetic efficacy of repeated milnacipran in persistent pain. In: American College of Reumatology. Annual scientific meeting. Atlanta; 2002. abstr. 191.
41. Simamoto E., Doi N., Suwa H. et al. A case of postherpetic neuralgia improved by milnacipran. J. Clin. Pharm. 2002; 5: 197-200.
42. Iyengar S., Webster A. A., Hermick-Luecre S. K. et al. Efficacy of duloxetine, a potent and balanced serotonin-norepin-phrine reuptake inhibitor in persistent pain models in rats. J. Pharmacol. Exp. Ther. 2004; 31 (2): 576-584.
43. Russian source